European Medicines Agency Makes Recommendations To Minimise Risk Of…

Main Category: Urology / Nephrology Also Included In: Regulatory Affairs / Drug Approvals Article Date: 22 Nov 2009 The European Medicines Agency has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents in patients at risk of developing the condition.

source : www.topix.com

Related News:

• Breast Enhancement Surgeon on Long Island Nominated a "Best Of"
• $16 Million Grant From State Stem Cell Agency To Speed Research Of…
• Book and Media Reviews: American Psychiatric Publishing Textbook of…
• After Mastectomy: Making a Decision About Breast Reconstruction
• Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of…
• UM Doctor To Lead Clinical Trial For ALS
• Migraine as inspiration
• Impax Pharmaceuticals Reports Positive Results of Phase II Trial of…
• Analysis of TB treatment studies identifies gaps in guidelines
• Weighing costs, benefits of HIV treatments

Details :
Submited at Sunday, November 22nd, 2009 at 1:00 pm on Urology by hilman
Comment RSS 2.0 - leave a comment - trackback